Saskia Güller

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

Gesine Bug, Andreas Burchert, Wagner Em et al. · Leukemia · 2017 · 86 citations · Full text

BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity.

Elena Puccetti, Saskia Güller, Anette Orleth et al. · PubMed · 2000 · 78 citations

Aberrant Kinase Activity, Mixed-phenotype Acute Leukemia, Apoptosis +19

Transcriptional Profiling of Human Hematopoiesis During In Vitro Lineage‐Specific Differentiation

Martina Komor, Saskia Güller, Claudia D. Baldus et al. · Stem Cells · 2005 · 54 citations · Full text

Transcriptional Profiling, Lymphocyte Development, Genetics +18

Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR-ABL and increases sensitivity to STI571

Elena Puccetti, Andrea Bianchini, Saskia Güller et al. · Blood · 2003 · 41 citations · Full text

Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis

Elena Puccetti, Saskia Güller, Jun E. Li et al. · Oncogene · 2003 · 20 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Leukemia-associated Translocation Products +9